The Major Brain Endocannabinoid 2-AG Controls Neuropathic Pain and Mechanical Hyperalgesia in Patients with Neuromyelitis Optica

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Pellkofer, Hannah L ^a,b   Havla, Joachim ^a   Hauer, Daniela ^a   Schelling, Gustav ^a   Azad, Shahnaz C ^a   Kuempfel, Tania ^a   Magerl, Walter ^c   Huge, Volker ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ENDOCANNABINOID;

ADULT; AGED; ALLODYNIA; ANALGESIC ACTIVITY; ARTICLE; BLOOD LEVEL; CHRONIC STRESS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DEAFFERENTATION PAIN; DEPRESSION; DISEASE ASSOCIATION; DYSESTHESIA; ENDOCANNABINOID BLOOD LEVEL; FEMALE; HEAT SENSATION; HEAT SENSITIVITY; HUMAN; HYPERALGESIA; MALE; MECHANICAL STIMULATION; MYELOOPTIC NEUROPATHY; NEUROMODULATION; NEUROPATHIC PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOLOGIC ASSESSMENT; QUANTITATIVE SENSORY TESTING; SENSORY ANALYSIS; SENSORY DYSFUNCTION; SPINAL CORD LESION;

EID: 84881248473     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071500     Document Type: Article

References (90)

1. Allbutt T (1870) On the opthalmoscopic signs of spinal disease. Lancet: 76-78.
2. Devic E, (1894) Myelite subaiguë compliquée de névrite optique. Bull Med 8: 1033-1034.
3. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG, (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53: 1107-1114.
4. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, et al. (2006) Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63: 964-968.
5. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG, (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485-1489.
6. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, et al. (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106-2112.
7. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR, (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202: 473-477.
8. Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, et al. (2009) Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 66: 617-629.
9. Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, et al. (2009) Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 66: 630-643.
10. Kanamori Y, Nakashima I, Takai Y, Nishiyama S, Kuroda H, et al. (2011) Pain in neuromyelitis optica and its effect on quality of life: a cross-sectional study. Neurology 77: 652-658.
11. Qian P, Lancia S, Alvarez E, Klawiter EC, Cross AH, et al. (2012) Association of Neuromyelitis Optica With Severe and Intractable Pain. Arch Neurol: 1-6.
12. Kurtzke JF, (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
13. Attal N, Fermanian C, Fermanian J, Lanteri-Minet M, Alchaar H, et al. (2008) Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion? Pain 138: 343-353.
14. Baron R, (2006) Mechanisms of disease: neuropathic pain-a clinical perspective. Nat Clin Pract Neurol 2: 95-106.
15. Maier C, Baron R, Tolle TR, Binder A, Birbaumer N, et al. (2010) Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 150: 439-450.
16. Rolke R, Magerl W, Campbell KA, Schalber C, Caspari S, et al. (2006) Quantitative sensory testing: a comprehensive protocol for clinical trials. European Journal of Pain 10: 77-88.
17. Rolke R, Baron R, Maier C, Tolle TR, Treede RD, et al. (2006) Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values. Pain 123: 231-243.
18. Magerl W, Krumova EK, Baron R, Tolle T, Treede RD, et al. (2010) Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain 151: 598-605.
19. Geber C, Klein T, Azad S, Birklein F, Gierthmuhlen J, et al. (2011) Test-retest and interobserver reliability of quantitative sensory testing according to the protocol of the German Research Network on Neuropathic Pain (DFNS): a multi-centre study. Pain 152: 548-556.
20. Cruccu G, Truini A, (2009) Tools for assessing neuropathic pain. PLoS Med 6: e1000045.
21. Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin CE, et al. (2007) Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci 10: 870-879.
22. Benedetti F, Amanzio M, Rosato R, Blanchard C, (2011) Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med 17: 1228-1230.
23. Johanek LM, Heitmiller DR, Turner M, Nader N, Hodges J, et al. (2001) Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms. Pain 93: 303-315.
24. Rog DJ, Nurmikko TJ, Friede T, Young CA, (2005) Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 65: 812-819.
25. Voscopoulos C, Lema M, (2010) When does acute pain become chronic? Br J Anaesth 105Suppl 1: i69-85.
26. Walter L, Franklin A, Witting A, Wade C, Xie Y, et al. (2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 23: 1398-1405.
27. Toth CC, Jedrzejewski NM, Ellis CL, Frey WH 2nd, (2010) Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain. Mol Pain 6: 16.
28. Katona I, Freund TF, (2008) Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. NatMed 14: 923-930.
29. Sigel E, Baur R, Racz I, Marazzi J, Smart TG, et al. (2011) The major central endocannabinoid directly acts at GABA(A) receptors. Proc Natl Acad Sci U S A 108: 18150-18155.
30. Kim J, Alger BE, (2010) Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat Neurosci 13: 592-600.
31. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, et al. (2005) Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114: 29-36.
32. Geber C, Magerl W, Fondel R, Fechir M, Rolke R, et al. (2008) Numbness in clinical and experimental pain- A cross-sectional study exploring the mechanisms of reduced tactile function. Pain 139: 73-81.
33. Vogeser M, Hauer D, Christina AS, Huber E, Storr M, et al. (2006) Release of anandamide from blood cells. Clin ChemLabMed 44: 488-491.
34. Vogeser M, Hauer D, Christina Azad S, Huber E, Storr M, et al. (2006) Release of anandamide from blood cells. Clin Chem Lab Med 44: 488-491.
35. Vogeser M, Schelling G, (2007) Pitfalls in measuring the endocannabinoid 2-arachidonoyl glycerol in biological samples. Clin ChemLabMed 45: 1023-1025.
36. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ, (1977) Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 106: 203-214.
37. Hautzinger M, Bailer M (1993) Allgemeine Depressionsskala (ADS). Weinheim: Beltz.
38. Geisser ME, Roth RS, Robinson ME, (1997) Assessing depression among persons with chronic pain using the Center for Epidemiological Studies-Depression Scale and the Beck Depression Inventory: a comparative analysis. Clin J Pain 13: 163-170.
39. Stoll C, Kapfhammer HP, Rothenhausler HB, Haller M, Briegel J, et al. (1999) Sensitivity and specificity of a screening test to document traumatic experiences and to diagnose post-traumatic stress disorder in ARDS patients after intensive care treatment. Intensive Care Med 25: 697-704.
40. Ware JE Jr, Sherbourne CD, (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473-483.
41. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, et al. (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70: 1630-1635.
42. Boivie J, (1989) On central pain and central pain mechanisms. Pain 38: 121-122.
43. Martinelli Boneschi F, Colombo B, Annovazzi P, Martinelli V, Bernasconi L, et al. (2008) Lifetime and actual prevalence of pain and headache in multiple sclerosis. Mult Scler 14: 514-521.
44. Osterberg A, Boivie J, Thuomas KA, (2005) Central pain in multiple sclerosis-prevalence and clinical characteristics. Eur J Pain 9: 531-542.
45. Osterberg A, Boivie J, (2010) Central pain in multiple sclerosis- sensory abnormalities. Eur J Pain 14: 104-110.
46. Solaro C, Brichetto G, Amato MP, Cocco E, Colombo B, et al. (2004) The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology 63: 919-921.
47. Fields HL, Rowbotham M, Baron R, (1998) Postherpetic Neuralgia: Irritable Nociceptors and Deafferentation. Neurobiology of Disease 5: 209-227.
48. Baumgartner U, Magerl W, Klein T, Hopf HC, Treede RD, (2002) Neurogenic hyperalgesia versus painful hypoalgesia: two distinct mechanisms of neuropathic pain. Pain 96: 141-151.
49. Jensen MP, Chodroff MJ, Dworkin RH, (2007) The impact of neuropathic pain on health-related quality of life: review and implications. Neurology 68: 1178-1182.
50. Huge V, Lauchart M, Magerl W, Beyer A, Moehnle P, et al. (2011) Complex interaction of sensory and motor signs and symptoms in chronic CRPS. PLoS One 6: e18775.
51. Lenz FA, Kwan HC, Dostrovsky JO, Tasker RR, (1989) Characteristics of the bursting pattern of action potentials that occurs in the thalamus of patients with central pain. Brain Res 496: 357-360.
52. Eschenfelder S, Habler HJ, Janig W, (2000) Dorsal root section elicits signs of neuropathic pain rather than reversing them in rats with L5 spinal nerve injury. Pain 87: 213-219.
53. Kim JS, Lee JH, Lee MC, (1997) Patterns of sensory dysfunction in lateral medullary infarction. Clinical-MRI correlation. Neurology 49: 1557-1563.
54. Zeilig G, Enosh S, Rubin-Asher D, Lehr B, Defrin R, (2012) The nature and course of sensory changes following spinal cord injury: predictive properties and implications on the mechanism of central pain. Brain 135: 418-430.
55. Finnerup NB, Johannesen IL, Bach FW, Jensen TS, (2003) Sensory function above lesion level in spinal cord injury patients with and without pain. Somatosens Mot Res 20: 71-76.
56. Wasner G, Lee BB, Engel S, McLachlan E, (2008) Residual spinothalamic tract pathways predict development of central pain after spinal cord injury. Brain 131: 2387-2400.
57. Marchand F, Perretti M, McMahon SB, (2005) Role of the immune system in chronic pain. Nat Rev Neurosci 6: 521-532.
58. Nakamura M, Miyazawa I, Fujihara K, Nakashima I, Misu T, et al. (2008) Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study. J Neurol 255: 163-170.
59. Gierthmuhlen J, Maier C, Baron R, Tolle T, Treede RD, et al. (2012) Sensory signs in complex regional pain syndrome and peripheral nerve injury. Pain 153: 765-774.
60. Boivie J, (2003) Central pain and the role of quantitative sensory testing (QST) in research and diagnosis. Eur J Pain 7: 339-343.
61. Magerl W, Fuchs PN, Meyer RA, Treede RD, (2001) Roles of capsaicin-insensitive nociceptors in cutaneous pain and secondary hyperalgesia. Brain 124: 1754-1764.
62. Simone DA, Sorkin LS, Oh U, Chung JM, Owens C, et al. (1991) Neurogenic hyperalgesia: central neural correlates in responses of spinothalamic tract neurons. J Neurophysiol 66: 228-246.
63. Woolf CJ, (2011) Central sensitization: implications for the diagnosis and treatment of pain. Pain 152: S2-15.
64. Finnerup NB, Johannesen IL, Fuglsang-Frederiksen A, Bach FW, Jensen TS, (2003) Sensory function in spinal cord injury patients with and without central pain. Brain 126: 57-70.
65. Magerl W, Wilk SH, Treede RD, (1998) Secondary hyperalgesia and perceptual wind-up following intradermal injection of capsaicin in humans. Pain 74: 257-268.
66. Woolf CJ, (1996) Windup and central sensitization are not equivalent. Pain 66: 105-108.
67. Treede RD, Meyer RA, Raja SN, Campbell JN, (1992) Peripheral and central mechanisms of cutaneous hyperalgesia. ProgNeurobiol 38: 397-421.
68. Wasner G, Schattschneider J, Binder A, Baron R, (2004) Topical menthol-a human model for cold pain by activation and sensitization of C nociceptors. Brain 127: 1159-1171.
69. Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, et al. (2010) Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133: 349-361.
70. Marignier R, Nicolle A, Watrin C, Touret M, Cavagna S, et al. (2010) Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury. Brain 133: 2578-2591.
71. Olechowski CJ, Truong JJ, Kerr BJ, (2009) Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain 141: 156-164.
72. Sandhir R, Gregory E, He YY, Berman NE, (2011) Upregulation of inflammatory mediators in a model of chronic pain after spinal cord injury. Neurochem Res 36: 856-862.
73. Nesic O, Lee J, Johnson KM, Ye Z, Xu GY, et al. (2005) Transcriptional profiling of spinal cord injury-induced central neuropathic pain. J Neurochem 95: 998-1014.
74. Hansen C, Hopf HC, Treede RD, (1996) Paradoxical heat sensation in patients with multiple sclerosis. Evidence for a supraspinal integration of temperature sensation. Brain 119: 1729-1736.
75. Susser E, Sprecher E, Yarnitsky D, (1999) Paradoxical heat sensation in healthy subjects: peripherally conducted by A{delta} or C fibres? Brain 122: 239-246.
76. Huge V, Lauchart M, Forderreuther S, Kaufhold W, Valet M, et al. (2008) Interaction of Hyperalgesia and Sensory Loss in Complex Regional Pain Syndrome Type I (CRPS I). PLoS ONE 3: e2742.
77. Zhang X, Wang J, Zhou Q, Xu Y, Pu S, et al. (2011) Brain-derived neurotrophic factor-activated astrocytes produce mechanical allodynia in neuropathic pain. Neuroscience 199: 452-460.
78. Hulsebosch CE, (2008) Gliopathy ensures persistent inflammation and chronic pain after spinal cord injury. Exp Neurol 214: 6-9.
79. Gwak YS, Kang J, Unabia GC, Hulsebosch CE, (2012) Spatial and temporal activation of spinal glial cells: role of gliopathy in central neuropathic pain following spinal cord injury in rats. Exp Neurol 234: 362-372.
80. Hald A, (2009) Spinal astrogliosis in pain models: cause and effects. Cell Mol Neurobiol 29: 609-619.
81. Kato A, Punnakkal P, Pernia-Andrade AJ, von Schoultz C, Sharopov S, et al. (2012) Endocannabinoid-dependent plasticity at spinal nociceptor synapses. J Physiol 590: 4717-4733.
82. Min R, Nevian T, (2012) Astrocyte signaling controls spike timing-dependent depression at neocortical synapses. Nat Neurosci 15: 746-753.
83. Ortinski PI, Dong J, Mungenast A, Yue C, Takano H, et al. (2010) Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci 13: 584-591.
84. Bukhari W, Barnett MH, Prain K, Broadley SA, (2012) Molecular pathogenesis of neuromyelitis optica. Int J Mol Sci 13: 12970-12993.
85. Willis CL, (2011) Glia-induced reversible disruption of blood-brain barrier integrity and neuropathological response of the neurovascular unit. Toxicol Pathol 39: 172-185.
86. Willis CL, (2012) Imaging in vivo astrocyte/endothelial cell interactions at the blood-brain barrier. Methods Mol Biol 814: 515-529.
87. Chouker A, Kaufmann I, Kreth S, Hauer D, Feuerecker M, et al. (2010) Motion sickness, stress and the endocannabinoid system. PLoS One 5: e10752.
88. Sticht MA, Long JZ, Rock EM, Limebeer CL, Mechoulam R, et al. (2012) Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats. Br J Pharmacol 165: 2425-2435.
89. Kallendrusch S, Hobusch C, Ehrlich A, Nowicki M, Ziebell S, et al. (2012) Intrinsic up-regulation of 2-AG favors an area specific neuronal survival in different in vitro models of neuronal damage. PLoS One 7: e51208.
90. Bar KJ, Greiner W, Letsch A, Kobele R, Sauer H, (2003) Influence of gender and hemispheric lateralization on heat pain perception in major depression. J Psychiatr Res 37: 345-353.